Introduction: The survival rate of cancer patients was high due to chemotherapy, but it can cause cardiotoxicity and increase morbidity and mortality. Most studies on cancer therapy-related cardiac dysfunction (CTRCD) focus more on the left ventricle. This study assesses chemotherapy's effect on the right ventricle, namely the right ventricle free wall longitudinal strain (RVFWLS). Methods: This study is a prospective cohort conducted from January to December 2022 on thirty-four cancer patients undergoing chemotherapy at Dr Wahidin Sudirohusodo Hospital Makassar. The RVFWLS was assessed before and after chemotherapy using echocardiographic. Result: The RVFWLS value after one cycle chemotherapy decreased compared pre-chemotherapy (4.40±4.8...
Background: Trastuzumab, used to treat breast cancer overexpressing human epidermal growth factor re...
The injury of the left ventricle (LV) during anticancer therapy has long been recognized, and guidel...
Background: Ever increasing therapeutic modalities in treatment of various malignancies has resulted...
Background: Anthracycline (ANT) is the most recognized therapy known to cause cardiotoxicity, mainly...
Background: Cardiotoxicity from anthracycline-based chemotherapy is an important cause of early and ...
BackgroundLeft ventricular dysfunction and cardiomyopathy are well documented adverse effects associ...
Objective: Cancer treatment-related cardiac dysfunction (CTRCD) is a significant concern for patient...
Copyright © 2015 Anna Calleja et al. This is an open access article distributed under the Creative C...
Background. Right ventricular (RV) dysfunction during cancer therapy related cardiotoxicity and its ...
Aim: This study aimed to investigate the effects of folinic acid and fluorouracil (bolus FUFA regime...
BACKGROUND: Global longitudinal strain (GLS) can predict cancer therapeutics-related cardiac dysfunc...
Background: Accurate diagnostic tools to identify patients at risk of cancer therapy-related cardi...
Introduction. Although epirubicin has significantly improved outcome in breast cancer (BC) patients,...
Introduction: Chemotherapy is one of the largest areas of pharmaceutical development. However, the n...
No study has examined myocardial work in subjects with cancer therapy-related cardiac dysfunction (C...
Background: Trastuzumab, used to treat breast cancer overexpressing human epidermal growth factor re...
The injury of the left ventricle (LV) during anticancer therapy has long been recognized, and guidel...
Background: Ever increasing therapeutic modalities in treatment of various malignancies has resulted...
Background: Anthracycline (ANT) is the most recognized therapy known to cause cardiotoxicity, mainly...
Background: Cardiotoxicity from anthracycline-based chemotherapy is an important cause of early and ...
BackgroundLeft ventricular dysfunction and cardiomyopathy are well documented adverse effects associ...
Objective: Cancer treatment-related cardiac dysfunction (CTRCD) is a significant concern for patient...
Copyright © 2015 Anna Calleja et al. This is an open access article distributed under the Creative C...
Background. Right ventricular (RV) dysfunction during cancer therapy related cardiotoxicity and its ...
Aim: This study aimed to investigate the effects of folinic acid and fluorouracil (bolus FUFA regime...
BACKGROUND: Global longitudinal strain (GLS) can predict cancer therapeutics-related cardiac dysfunc...
Background: Accurate diagnostic tools to identify patients at risk of cancer therapy-related cardi...
Introduction. Although epirubicin has significantly improved outcome in breast cancer (BC) patients,...
Introduction: Chemotherapy is one of the largest areas of pharmaceutical development. However, the n...
No study has examined myocardial work in subjects with cancer therapy-related cardiac dysfunction (C...
Background: Trastuzumab, used to treat breast cancer overexpressing human epidermal growth factor re...
The injury of the left ventricle (LV) during anticancer therapy has long been recognized, and guidel...
Background: Ever increasing therapeutic modalities in treatment of various malignancies has resulted...